
According to our new research report, “Global Vaccine Market Forecast to 2013”, vaccines have emerged as one of the key measures for the prevention of several life-threatening diseases worldwide. Backed by factors, such as huge potential in emerging countries and significant increase in the incidences of life-threatening diseases, the global vaccine market reached the mark of US$ 25.3 Billion in 2010. In future, among all the key market segments, cancer vaccines, influenza vaccines, and pneumococcal vaccines are expected to perform relatively well compared to the others.